Mind-body Resiliency Intervention for Fear of Cancer Recurrence
Completed · Not applicable
Conditions studied: Cancer, Coping Skills, Coping Behavior
In brief
The purpose of this study is to test the feasibility of a virtual, group mind-body resiliency intervention adapted to target fear of recurrence (FOR) among cancer survivors.
Key facts
- Study ID
- NCT04876599
- Run by
- Massachusetts General Hospital
- People needed
- 64
- Starts
- 2021-07-09
- Expected to finish
- 2023-08-31
- Last updated by the study team
- 2023-10-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- History of non-metastatic, localized, or regional solid or blood malignancy(ies)
- Completion of primary cancer treatment (i.e., radiation, surgery, chemotherapy) and/or current use of long-term maintenance hormonal or biologic therapy
- Age ≥18 years
- Elevated fear of recurrence (FCRI severity score ≥16)
- MGB/BIDMC Medical Record Number (MRN)
You may not qualify if…
- Self-reported inability to speak and write in English
- Undertreated serious mental illness as defined by history of suicidality, psychosis, and/or psychiatric hospitalization in the past year
- Inability to access technology and/or sufficient internet to participate virtual groups sessions
Where it is running
- Massachusett General Hospital Cancer Center — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Mass General at Emerson Hospital -- Bethke — Concord, Massachusetts, United States
- Mass General/North Shore Cancer Center — Danvers, Massachusetts, United States
- Newton-Wellesley Hospital — Newton, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.